Display Settings:

Format

Send to:

Choose Destination
    Antimicrob Agents Chemother. 2006 Feb;50(2):474-9.

    Novel compounds active against Leishmania major.

    Source

    MycoLogics, Inc., 12635 E. Montview Blvd., Suite 215, Aurora, CO 80010, USA.

    Abstract

    Leishmania major is an important trypanosomatid pathogen that causes leishmaniasis, which is a serious disease in much of the Old World. Current treatments include a small number of antimony compounds that, while somewhat effective, are limited by serious side effects. We have screened a small portion of a unique chemical library and have found at least three novel compounds that are effective against L. tarentolae and L. major in vitro and in a murine macrophage model of L. major infection. These compounds were effective in both assays at doses significantly lower than those of sodium stibogluconate (Pentostam) and represent possible candidates for drug development.

    PMID:
    16436699
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1366913
    Free PMC Article

    Images from this publication.See all images (3) Free text

    FIG. 3.
    FIG. 1.
    FIG. 2.

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk